JAK inhibitors in dermatology: The promise of a new drug class
Sign Up to like & getrecommendations! Published in 2017 at "Journal of the American Academy of Dermatology"
DOI: 10.1016/j.jaad.2016.12.005
Abstract: &NA; New molecularly targeted therapeutics are changing dermatologic therapy. Janus kinase–signal transducer and activator of transcription (JAK‐STAT) is an intracellular signaling pathway upon which many different proinflammatory signaling pathways converge. Numerous inflammatory dermatoses are driven… read more here.
Keywords: dermatology; class; inhibitors dermatology; dermatology promise ... See more keywords